These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15184587)

  • 1. Is "seronegative" MG explained by autoantibodies to MuSK?
    Lindstrom J
    Neurology; 2004 Jun; 62(11):1920-1. PubMed ID: 15184587
    [No Abstract]   [Full Text] [Related]  

  • 2. Is "seronegative" MG explained by autoantibodies to MuSK?
    Vincent AC; McConville J; Newsom-Davis J
    Neurology; 2005 Jan; 64(2):399; author reply 399. PubMed ID: 15668461
    [No Abstract]   [Full Text] [Related]  

  • 3. Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese.
    Yeh JH; Chen WH; Chiu HC; Vincent A
    Neurology; 2004 Jun; 62(11):2131-2. PubMed ID: 15184635
    [No Abstract]   [Full Text] [Related]  

  • 4. MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG.
    Ohta K; Shigemoto K; Kubo S; Maruyama N; Abe Y; Ueda N; Ohta M
    Neurology; 2004 Jun; 62(11):2132-3. PubMed ID: 15184636
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-MuSK positivity on plasmapheresis liquid in a double seronegative myasthenia gravis patient.
    Renard D; Candon S; Jacob M; Trusson R; Reboul P
    Acta Neurol Belg; 2018 Mar; 118(1):119-120. PubMed ID: 28608313
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy.
    Deguchi K; Matsuzono K; Nakano Y; Kono S; Sato K; Deguchi S; Tanabe K; Hishikawa N; Ota Y; Yamashita T; Ohta K; Motomura M; Abe K
    Intern Med; 2018 May; 57(10):1455-1458. PubMed ID: 29321424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSK-mediated myasthenia gravis.
    O'carroll P; Bertorini TE; Jacob G; Mitchell CW; Graff J
    J Clin Neuromuscul Dis; 2009 Dec; 11(2):69-71. PubMed ID: 19955986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MuSK Ab described in seropositive MG sera found to be Ab to alkaline phosphatase.
    Ohta K; Shigemoto K; Kubo S; Maruyama N; Abe Y; Ueda N; Fujinami A; Ohta M
    Neurology; 2005 Dec; 65(12):1988. PubMed ID: 16380629
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical aspects of MuSK antibody positive seronegative MG.
    Sanders DB; El-Salem K; Massey JM; McConville J; Vincent A
    Neurology; 2003 Jun; 60(12):1978-80. PubMed ID: 12821744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts.
    Guptill JT; Sanders DB; Evoli A
    Muscle Nerve; 2011 Jul; 44(1):36-40. PubMed ID: 21674519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are MuSK antibodies the primary cause of myasthenic symptoms?
    Selcen D; Fukuda T; Shen XM; Engel AG
    Neurology; 2004 Jun; 62(11):1945-50. PubMed ID: 15184594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance plasma exchange treatment for muscle specific kinase antibody positive myasthenia gravis patients.
    Yamada C; Teener JW; Davenport RD; Cooling L
    J Clin Apher; 2015 Oct; 30(5):314-9. PubMed ID: 25557356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seronegative myasthenia gravis.
    Vincent A; McConville J; Farrugia ME; Newsom-Davis J
    Semin Neurol; 2004 Mar; 24(1):125-33. PubMed ID: 15229799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Seronegative myasthenia gravis].
    Gajdos P
    Rev Neurol (Paris); 2004 Feb; 160(2):159-62. PubMed ID: 15034472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of myasthenia gravis with anti-MuSK antibodies showing a dramatic improvement with plasma exchange].
    Suzuki H; Motomura M; Yoshimura T; Shiraishi H; Mitsui Y; Hasegawa T; Atsumi M; Kitaguchi M; Kusunoki S
    Rinsho Shinkeigaku; 2005 Jul; 45(7):510-3. PubMed ID: 16119834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive transfer models of myasthenia gravis with muscle-specific kinase antibodies.
    Verschuuren JJGM; Plomp JJ; Burden SJ; Zhang W; Fillié-Grijpma YE; Stienstra-van Es IE; Niks EH; Losen M; van der Maarel SM; Huijbers MG
    Ann N Y Acad Sci; 2018 Feb; 1413(1):111-118. PubMed ID: 29356029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial autoimmune MuSK positive myasthenia gravis.
    Corda D; Deiana GA; Mulargia M; Pirastru MI; Serra M; Piluzza MG; Carcassi C; Sechi G
    J Neurol; 2011 Aug; 258(8):1559-60. PubMed ID: 21369718
    [No Abstract]   [Full Text] [Related]  

  • 18. The auto-antigen repertoire in myasthenia gravis.
    Vrolix K; Fraussen J; Molenaar PC; Losen M; Somers V; Stinissen P; De Baets MH; Martínez-Martínez P
    Autoimmunity; 2010 Aug; 43(5-6):380-400. PubMed ID: 20380581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
    Deymeer F; Gungor-Tuncer O; Yilmaz V; Parman Y; Serdaroglu P; Ozdemir C; Vincent A; Saruhan-Direskeneli G
    Neurology; 2007 Feb; 68(8):609-11. PubMed ID: 17310034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)].
    Sanadze AG; Sidnev DV; Karganov MIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):72-6. PubMed ID: 21311492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.